Skip to content

To Explore The New Way Of Treating Essential Hypertension: A study Comparing Cratagus Oxycanths VS Individual Homeopathic Medicine

A Comparative Clinical Study Of Effectiveness Of Individual Homoeopathic Medicine Against Cratagus Oxycantha Mother Tincture In Cases Of Stress Induced Essential Hypertension In Young Age Group Of 18 to 35 Years - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080668
Enrollment
100
Registered
2025-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Crataegus Oxyacantha: - Dose: 5 drops in 1 cup of water. - Frequency: Administered every 15 days. - Route of Administration: Oral. - Total Duration: 6 months. - Additional Details: Bloo

Sponsors

Vidhyadeep Homoeopathic Medical College And Research Center Anita Kim
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Individuals between the ages of eighteen to thirty-five years. 2) Diagnosed or undiagnosed cases of stress-induced essential hypertension, defined as systolic blood pressure of one hundred thirty millimeters of mercury or higher and/or diastolic blood pressure of eighty millimeters of mercury or higher. 3) Participants experiencing chronic stress due to factors such as work-related pressures, marital conflicts, low socioeconomic status, or lack of social support. 4) Individuals of both male and female genders who are willing to participate in the study and adhere to the treatment and follow-up schedule. 5) Participants who are not currently taking any medications for high blood pressure. 6) Individuals without any history of substance abuse, including alcohol or drug use, and without any critical systemic diseases or severe medical conditions.

Exclusion criteria

Exclusion criteria: 1) Individuals who are outside the age range of eighteen to thirty-five years. 2) Participants who have irregular follow-up or are unwilling to comply with the study protocol. 3) Individuals who have been diagnosed with hypertension and are currently receiving any form of medication for high blood pressure. 4) Participants with a history of substance abuse, including long-term alcohol consumption or drug use. 5) Cases with severe medical conditions or poor health prognosis that may interfere with their ability to participate in the study. 6) Individuals diagnosed with systemic diseases, including kidney disorders, liver diseases, or heart conditions. 7) Women who are pregnant or breastfeeding. Participants who are undergoing any other complementary or alternative treatments for high blood pressure.

Design outcomes

Primary

MeasureTime frame
Reduction in Systolic and Diastolic Blood Pressure (measured in millimeters of mercury)Timepoint: Baseline, 4 weeks & 8 weeks

Secondary

MeasureTime frame
Assessed using validated questionnaires or scalesTimepoint: Measured at baseline, at four weeks, at eight weeks, & at the end of the six-month treatment period.

Countries

India

Contacts

Public ContactDr Vipul R Shastri

Vidhyadeep Homoeopathic Medical College And Research Centre Vidhyadeep University

dr.radha.mangukiya@vidhyadeepuni.ac.in9879998290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026